{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:13:37Z","timestamp":1761959617716,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T00:00:00Z","timestamp":1647993600000},"content-version":"vor","delay-in-days":81,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.lrr.2022.100306","type":"journal-article","created":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T23:02:03Z","timestamp":1648162923000},"page":"100306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Expanding diagnostic criteria: Multiorgan T-Cell\/myeloid mixed phenotype acute leukemia with t(v;11q23) KMT2A-rearrangement successfully treated by allogeneic stem cell transplant"],"prefix":"10.1016","volume":"17","author":[{"given":"Suhayb","family":"Syed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8785-8162","authenticated-orcid":false,"given":"Amy","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5192-0489","authenticated-orcid":false,"given":"Mohammad","family":"Hussaini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lrr.2022.100306_bib0001","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12929-020-00674-7","article-title":"Genomic landscape in acute myeloid leukemia and its implications in risk classification and targeted therapies","volume":"27","author":"Hou","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.lrr.2022.100306_bib0002","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1182\/asheducation-2004.1.98","article-title":"Acute myeloid leukemia","author":"Stone","year":"2004","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"issue":"1","key":"10.1016\/j.lrr.2022.100306_bib0003","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1182\/asheducation-2016.1.580","article-title":"T-cell acute lymphoblastic leukemia","author":"Raetz","year":"2016","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"issue":"9","key":"10.1016\/j.lrr.2022.100306_bib0004","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1182\/blood-2016-07-692608","article-title":"Management of adults with T-cell lymphoblastic leukemia","volume":"129","author":"Marks","year":"2017","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.lrr.2022.100306_bib0005","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1038\/leu.2010.202","article-title":"Mixed-phenotype acute leukemia: historical overview and a new definition","volume":"24","author":"Weinberg","year":"2010","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.lrr.2022.100306_bib0006","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.5858\/arpa.2017-0218-RA","article-title":"Mixed-Phenotype Acute leukemia: diagnostic criteria and pitfalls","volume":"141","author":"Charles","year":"2017","journal-title":"Arch. Pathol. Lab Med."},{"issue":"16","key":"10.1016\/j.lrr.2022.100306_bib0007","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1182\/blood-2014-10-551465","article-title":"How I treat mixed-phenotype acute leukemia","volume":"125","author":"Wolach","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.lrr.2022.100306_bib0008","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5045\/br.2019.54.1.63","article-title":"Biphenotypic acute leukemia or acute leukemia of ambiguous lineage in childhood: clinical characteristics and outcome","volume":"54","author":"Lee","year":"2019","journal-title":"Blood Res."},{"issue":"4","key":"10.1016\/j.lrr.2022.100306_bib0009","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ng.542","article-title":"PHF6 mutations in T-cell acute lymphoblastic leukemia","volume":"42","author":"Van Vlierberghe","year":"2010","journal-title":"Nat. Genet"},{"issue":"1","key":"10.1016\/j.lrr.2022.100306_bib0010","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12967-020-02500-y","article-title":"Chronic loss of STAG2 leads to altered chromatin structure contributing to de-regulated transcription in AML","volume":"18","author":"Smith","year":"2020","journal-title":"J. Transl. Med."},{"issue":"8","key":"10.1016\/j.lrr.2022.100306_bib0011","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/ng.3909","article-title":"The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia","volume":"49","author":"Liu","year":"2017","journal-title":"Nat. Genet"},{"key":"10.1016\/j.lrr.2022.100306_bib0012","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.2147\/CMAR.S196574","article-title":"T-lymphoid\/myeloid mixed phenotype acute leukemia and early T-cell precursor lymphoblastic leukemia similarities with NOTCH1 mutation as a good prognostic factor","volume":"11","author":"Noronha","year":"2019","journal-title":"Cancer Manag. Res."},{"issue":"9","key":"10.1016\/j.lrr.2022.100306_bib0013","doi-asserted-by":"crossref","first-page":"8441","DOI":"10.18632\/oncotarget.23878","article-title":"Mixed phenotype acute leukemia contains heterogeneous genetic mutations by next-generation sequencing","volume":"9","author":"Quesada","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.lrr.2022.100306_bib0014","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.leukres.2016.04.002","article-title":"Comparison of outcomes in mixed phenotype acute leukemia patients treated with chemotherapy and stem cell transplantation versus chemotherapy alone","volume":"45","author":"Tian","year":"2016","journal-title":"Leuk Res."},{"issue":"6","key":"10.1016\/j.lrr.2022.100306_bib0015","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jtct.2021.02.032","article-title":"Early T-Cell precursor acute lymphoblastic leukemia and T\/Myeloid mixed phenotype acute leukemia possess overlapping characteristics and both benefit from CAG-like regimens and allogeneic hematopoietic stem cell transplantation","volume":"27","author":"Liu","year":"2021","journal-title":"Transplant Cell Ther."},{"issue":"6","key":"10.1016\/j.lrr.2022.100306_bib0016","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1200\/JCO.20.02333","article-title":"Clinical implications of minimal residual disease detection in infants with KMT2A-rearranged acute lymphoblastic leukemia treated on the interfant-06 protocol","volume":"39","author":"Stutterheim","year":"2021","journal-title":"J. Clin. Oncol."}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048922000188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048922000188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:09:28Z","timestamp":1761959368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048922000188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":16,"alternative-id":["S2213048922000188"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2022.100306","relation":{},"ISSN":["2213-0489"],"issn-type":[{"type":"print","value":"2213-0489"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expanding diagnostic criteria: Multiorgan T-Cell\/myeloid mixed phenotype acute leukemia with t(v;11q23) KMT2A-rearrangement successfully treated by allogeneic stem cell transplant","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2022.100306","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100306"}}